Identification and treatment of Strongyloides stercoralis infection in a Boston Terrier dog from south‐eastern Australia

• Published in: Australian veterinary journal Vol. 102; no. 1-2; pp. 35 - 40
• Main Authors: Chapman, SA, Angles, JM, Raw, C, Zendejas‐Heredia, PA, Traub, RJ
• Format: Journal Article
• Language: English
• Published: Melbourne Wiley Publishing Asia Pty Ltd 01.01.2024; Wiley Subscription Services, Inc
• Subjects: canine; Diarrhea; Dogs; Immunocompromised hosts; Infections; Ivermectin; Nematodes; Parasitic diseases; qPCR, Baermann; Small intestine; Strongyloides stercoralis; Strongyloidiasis; Australia; canine; qPCR, Baermann; ivermectin; Strongyloides stercoralis
• ISSN: 0005-0423; 1751-0813
• DOI: 10.1111/avj.13300

Strongyloides stercoralis, the causative agent of strongyloidiasis, is a potentially zoonotic intestinal nematode endemic to northern Australia. Strongyloidiasis is typically observed in immunocompromised hosts and is characterised by gastrointestinal signs, respiratory symptoms and a failure to thrive. In immunocompromised hosts, hyperinfection syndrome and disseminated infections can prove life‐threatening. A 24‐month‐old Boston Terrier dog was referred for investigation of chronic small and large intestinal watery hematochezic diarrhoea, emaciation and hematemesis. Small intestinal histology identified a nematode despite consecutive negative faecal flotations. A real‐time polymerase chain reaction and Baermann test subsequently confirmed infection with S. stercoralis. The dog had received an oral parasiticide comprising milbemycin oxime and afoxolaner every month for the 11 months prior to this diagnosis. Despite fenbendazole being reported as successful in the treatment of canine strongyloidiasis, a course of fenbendazole failed to clear the infection. Eradication of S. stercoralis infection was confirmed after the administration of off‐label ivermectin fortnightly for 12 doses. Attention should be paid to this nematode as the failure of routine copromicroscopic methods to diagnose S. stercoralis infections can result in misdiagnosis, mistreatment and progression of the disease. Off‐label ivermectin may be an alternative to fenbendazole for the treatment of Strongyloides spp. infection in dogs.